Otolaryngology Doctors in Camden, NJ Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Kathryn Landers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 856-632-2667

Lucia Diaz Garcia, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 403, Camden, NJ 08103 Phone: 856-342-3275

Dr. Beth R Duncan, MD, MBA Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 411, Camden, NJ 08103 Phone: 856-342-3275    Fax: 856-968-8468

Dr. Thomas Christopher Spalla, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Camden, NJ 08103 Phone: 856-342-3113

Yekaterina A Koshkareva, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 855-632-2667

Dr. Donald H. Solomon, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 403, Camden, NJ 08103 Phone: 856-342-2439

Patrick Houston, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 411, Camden, NJ 08103 Phone: 856-342-3275    Fax: 856-968-8468

Dr. Nadir Ahmad, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 403, Camden, NJ 08103 Phone: 856-342-2439

Sunny Park, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Sutie 411, Camden, NJ 08103 Phone: 856-342-3275    Fax: 856-968-8468

News Archive

AACN PEARL provides one-stop convenience for nurses, other healthcare professionals

A new clinical resource from the American Association of Critical-Care Nurses (AACN) provides one-stop convenience for nurses, clinicians and other healthcare professionals seeking evidence-based knowledge and tools to help them improve patient outcomes.

FDA issues revised draft guidance to improve premarket safety notifications for new dietary ingredients

The U.S. Food and Drug Administration today issued a revised draft guidance to improve dietary supplement companies' new dietary ingredient (NDI) premarket safety notifications to the agency. These notifications help the agency identify safety concerns before products reach consumers.

Court of Appeals rules in favor of Mylan in Oxybutynin patent case

Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.

Lung cancer study highlights important factors for treating genomically complicated cancers

A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.

Read more Medical News

› Verified 2 days ago